| Primary |
| Hyperuricaemia |
34.0% |
| Gout |
29.4% |
| Product Used For Unknown Indication |
20.6% |
| Hypertension |
2.7% |
| Arthralgia |
1.9% |
| Tumour Lysis Syndrome |
1.9% |
| Atrial Fibrillation |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Gouty Arthritis |
1.1% |
| Gouty Tophus |
1.1% |
| Pain |
0.8% |
| Prophylaxis |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Hyperuricemia |
0.4% |
| Acute Myeloid Leukaemia |
0.4% |
| Autoimmune Disorder |
0.4% |
| Blood Culture Positive |
0.4% |
| Blood Uric Acid Increased |
0.4% |
| Cardiac Failure |
0.4% |
| Chronic Myeloid Leukaemia |
0.4% |
|
| Cardiac Failure |
10.4% |
| Urticaria |
9.1% |
| Hypertensive Crisis |
7.8% |
| Rash |
6.5% |
| Renal Failure |
6.5% |
| Condition Aggravated |
5.2% |
| Renal Failure Acute |
5.2% |
| Rhabdomyolysis |
5.2% |
| Circulatory Collapse |
3.9% |
| Dermatitis Allergic |
3.9% |
| Erythema Multiforme |
3.9% |
| Ischaemic Stroke |
3.9% |
| Leukocytoclastic Vasculitis |
3.9% |
| Pneumonia |
3.9% |
| Pruritus |
3.9% |
| Pyrexia |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Toxic Skin Eruption |
3.9% |
| Acidosis |
2.6% |
| Acute Hepatic Failure |
2.6% |
|
| Secondary |
| Urate Nephropathy |
42.9% |
| Gout |
28.6% |
| Acute Myeloid Leukaemia |
14.3% |
| Diabetes Mellitus |
14.3% |
|
| Oedema Peripheral |
66.7% |
| Stenotrophomonas Infection |
33.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
66.7% |
| Cough |
11.1% |
| Gouty Arthritis |
11.1% |
| Skin Abrasion |
11.1% |
|
| Renal Failure Acute |
40.0% |
| Osteoarthritis |
20.0% |
| Renal Impairment |
20.0% |
| Respiratory Fatigue |
20.0% |
|
